Medidata’s clinical protocol authoring and trial design tool takes top honors in clinical trial and research category.
New York, NY-May 2, 2008-Medidata Solutions (www.mdsol.com), a global provider of clinical trial technology, today announced that Medidata Designer™ has been selected as the winner of Bio-IT World magazine’s Best of Show award in the Clinical Trials and Research category. Medidata Designer was chosen from a group of more than 30 companies in the clinical technology space and was honored at the Bio-IT World Conference and Expo, held April 28–30, 2008, in Boston, MA.
“Medidata Designer emerged as the clear leader in the Clinical Trials and Research category in this year?s competition,” said Stephen Fogelson, president of Develotron LLC and one of the judges for the Best of Show awards. “While we received and reviewed a number of impressive submissions, Medidata Designer stood out from the rest due to its ability to bring significant value to clinical researchers by eliminating inconsistency errors and improving the overall quality of clinical protocols.”
A top recognition in the life sciences space, this award demonstrates Medidata’s commitment to advancing clinical trial solutions through innovative technology. As an electronic protocol authoring tool, Medidata Designer captures both the textual description of a study as well as a structured, electronic model of the trial specifications that can be leveraged downstream in clinical and operational study management and design. The product brings better quality, consistency and control to the protocol authoring process and delivers tangible benefits to medical writers, clinicians, and statisticians who author the protocol and other associated study documents. Furthermore, Medidata Designer can automatically configure other clinical trial systems-such as electronic data capture (EDC), clinical trial management (CTMS), electronic patient reported outcomes (ePRO), data analysis, and electronic data submissions-ensuring an automated environment for consistent, shared clinical and operational requirements.
“We are thrilled to have been selected as a Best of Show award winner and recognized as one of the most innovative clinical trial technology organizations in the industry,” said Ed Seguine, general manager of trial planning solutions at Medidata Solutions. “The selection of Medidata Designer as a Best of Show winner emphasizes our development team’s dedication to providing life science companies with the tools they need to drive significant efficiencies across the clinical trial process and for all members of the clinical research team.”
The Best of Show awards program is judged by a team of Bio-IT World magazine editors and leading industry experts and spotlights new products that demonstrate exceptional technology innovation across the life sciences research, discovery, and clinical trials process. Winners were chosen among entries submitted from leading bio-IT vendors exhibiting at the annual conference and expo, based on the products’ technical merit, functionality, and innovation. Finalists were chosen from seven categories, including Clinical Trials and Research, Basic Research/R&D, Drug Discovery & Development, Translational & Personalized Medicine, Business & Economic Development, IT Infrastructure/Knowledge Management, and Chemistry & Compounds.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.